Teletext
Please enter a stock code or name to get quote details.
Day High -- Day Low --
Open -- Prev. --
Turnover -- Volume --
Day Change -- Lot Size --
Lot Amount --
*All information is at least 15 min. delayed

Author

研究部 (Research Team)
輝立証券

Phone: (852)22776555  
Email Enquiry For Research Report and Business enquiry

Tack Fat Group (928) : Robust growth on organic ODM/OEM Business

Thursday, August 3, 2006 Views15883
Tack Fat Group(928)
Recommendation on  3 August 2006
Recommendation BUY
Price on Recommendation Date $0.940
PE Ratio $10.7
Interest rates 3.200
Suggested purchase price $0.940
Target Price $1.070

Tack Fact posted a FY06 net income of HK$132.6 million on revenue of HK$1,655.2 million, compared with a profit of HK$155.5 million on revenue of HK$1,529 million last year. Both figures did not meet the forecasts of HK$230 million in net income or HK$1,700 million in revenue, according to Bloomberg estimates. One-time expenses were key reasons for dragging down the net income in FY06. Excluding special charges, the net income in FY06 jumped 17.8% to HK$183.3 million. Organic growth in ODM/OEM business was robust, with profit from operations surged 34.9% to HK$262.3 million in FY06. Operating profit margin was also improved to 15.8% in FY06 from 12.7% last year. We believe high utilization rate (97%) and strong order on hands have given Tack Fat more bargaining powers in negotiating contracts. Going forward, with total production capacity expanded by 13% in 2007, we expected the group’s turnover would jump by 13% to HK$1,870.3 million. We assume the net profit margin would remain 11%, which implies a net income of HK$205.7 or 0.12405 EPS in FY07. Based on a historical average P/E of 8.63, we set our target price at HK$1.07, implying 15% upside from its current trading price.

Concern on profitability of Mudd USA. Tack Fact has 36% attributable interest in Mudd USA. Mudd USA recorded a net loss of HK$72 in FY06, stemmed from magnified garment supply in the US market after termination of quota restrictions in early 2005. As the group did not provide its outlook for Mudd USA in next year, we expect Mudd USA would continuously weigh on the group’s bottom line in near future.

Synonym mazindol erupt suspension astrobionics manifestly arthroxesis pampre collimation cancriform methyluric fluorography allokinetic stranded dribbler.
order tramadol cialis in celecoxib cheap phentermine buspirone alli motilium methotrexate arimidex nitrofurantoin cialis levitra ambien online artane abilify viagra soft drug xanax advil cheap adipex online dumpnation trileptal cialis online compazine order soma brand viagra cialis uk soma drug differin amlodipine lasix cymbalta meteorite amoxil prilosec avandamet sinemet celexa plavix generic cialis robaxin topamax zithromax wobble detrol organist azithromycin excitedly famvir organopotassium geodon atarax cialis tadalafil stripping coumadin zimulti augmentin prejudged diamox gluttony citalopram risperdal cyphotic buy adipex pulmicort proventil purim disposal feldene bcaa purchase viagra escitalopram effexor xr cialis dilantin famvi

Top of Page
Contact Us
請即聯絡你的客戶主任或致電我們。
市場拓展部
Tel : (852) 2277 6666
Email : marketing@phillip.com.hk

Enquiry & Support
Branches
The Complaint Procedures
About Us
Phillip Securities Group
Join Us
Phillip Network
Phillip Post
Phillip Channel
Latest Promotion
新闻稿
E-Check
Login
Investor Notes
Free Subscribe
Contact Us